Wernau Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Wernau Asset Management's PFE Position: Q3 2026 in Review
Wernau Asset Management reduced its Pfizer (PFE) stake by 2.3% in Q3 2026, selling an estimated $73.8K and leaving 116,951 shares worth $3.34M. The position accounts for 1.54% of the portfolio, ranked #10.
Wernau Asset Management first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.2M in Q1 2025. 2,016 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Wernau Asset Management held 116,951 shares of Pfizer worth $3.34M as of Q3 2026.
- Wernau Asset Management sold 2,774 Pfizer shares in Q3 2026, an estimated $73.8K.
- Pfizer made up 1.54% of Wernau Asset Management's portfolio in Q3 2026, its #10 holding.
- Wernau Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
- Wernau Asset Management's Pfizer position peaked at $4.2M in Q1 2025.
- 2,016 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Wernau Asset Management's 13F filing for Q3 2026, filed 19 Oct 2026.